telmisartan has been researched along with Weight Gain in 15 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 4 (26.67) | 29.6817 |
2010's | 9 (60.00) | 24.3611 |
2020's | 2 (13.33) | 2.80 |
Authors | Studies |
---|---|
Frydrychowicz, A; Hübner, N; Kuerschner, L; Nickel, L; Othman, A; Raasch, W; Rawish, E; Saar, K; Schuster, F; Stölting, I | 1 |
Beckmann, L; Busch, H; Freitag, M; Freschi, ML; Fuchs, B; Galuska, CE; Hirose, M; Huber, G; Ibrahim, SM; Knobloch, JK; Künstner, A; Langan, EA; Matschl, U; Raasch, W; Stölting, I | 1 |
Barkhausen, J; Hübel, N; Mildner, M; Müller-Fielitz, H; Raasch, W; Vogt, FM | 1 |
Braszko, JJ; Wincewicz, D | 1 |
Altuntas, A; Demir, M; Kutlucan, A; Kutlucan, L; Sezer, MT; Tunc, N; Turker, Y; Ugan, Y | 1 |
Bader, M; Barkhausen, J; Raasch, W; Santos, RA; Schuchard, J; Schuster, F; Stölting, I; Thorns, C; Vogt, FM; Winkler, M | 1 |
Aubert, G; Burnier, M; Dulloo, A; Mazzolai, L; Perregaux, C; Pralong, F; Zanchi, A | 1 |
Limor, R; Oron, Y; Rosenthal, T; Stern, N; Younis, F; Zangen, S | 1 |
Cao, T; Feng, X; He, H; Liu, D; Luo, Z; Ma, L; Ma, S; Tepel, M; Yan, Z; Yang, D; Zhu, Z | 1 |
Fujisawa, K; Kuwashiro, S; Matsumoto, T; Nishina, H; Oishi, T; Sakaida, I; Terai, S | 1 |
Jöhren, O; Miesel, A; Müller-Fielitz, H; Raasch, W; Vogt, FM | 1 |
Avery, MA; Benson, SC; Chittiboyina, A; Desai, P; Ho, CI; Kurtz, TW; Pershadsingh, HA; Pravenec, M; Qi, N; Wang, J | 1 |
Kazdová, L; Kurtz, TW; Ogihara, T; Pravenec, M; Qi, NR; Sugimoto, K | 1 |
Burnier, M; Dulloo, AG; Montani, JP; Perregaux, C; Zanchi, A | 1 |
Hyakukoku, M; Kazdová, L; Kren, V; Kurtz, TW; Pravenec, M; Qi, NR; Simáková, M; Sugimoto, K; Zídek, V | 1 |
1 trial(s) available for telmisartan and Weight Gain
Article | Year |
---|---|
Does the inhibition of renin-angiotensin system decrease inter-dialytic weight gain in anuric hemodialysis patients?
Topics: Adult; Aged; Angiotensin II Type 1 Receptor Blockers; Anuria; Benzimidazoles; Benzoates; Double-Blind Method; Female; Humans; Male; Middle Aged; Prospective Studies; Renal Dialysis; Renin-Angiotensin System; Telmisartan; Weight Gain | 2015 |
14 other study(ies) available for telmisartan and Weight Gain
Article | Year |
---|---|
Telmisartan prevents development of obesity and normalizes hypothalamic lipid droplets.
Topics: Angiotensin II Type 1 Receptor Blockers; Animal Feed; Animals; Diet, High-Fat; Hypothalamus; Leptin; Lipid Droplets; Lipid Metabolism; Mice; Mice, Inbred C57BL; Obesity; Telmisartan; Weight Gain | 2020 |
Telmisartan induces a specific gut microbiota signature which may mediate its antiobesity effect.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Anti-Obesity Agents; Bacteria; Diet; Disease Models, Animal; Dysbiosis; Fecal Microbiota Transplantation; Feces; Gastrointestinal Microbiome; Mice; Obesity; Rats; Rats, Sprague-Dawley; Telmisartan; Weight Gain | 2021 |
Chronic blockade of angiotensin AT₁ receptors improves cardinal symptoms of metabolic syndrome in diet-induced obesity in rats.
Topics: Amlodipine; Angiotensin II Type 1 Receptor Blockers; Animals; Anti-Obesity Agents; Antihypertensive Agents; Behavior, Animal; Benzimidazoles; Benzoates; Diet, High-Fat; Dietary Sucrose; Drug Therapy, Combination; Energy Intake; Hyperlipidemias; Hypertension; Hypolipidemic Agents; Insulin Resistance; Leptin; Male; Metabolic Syndrome; Obesity; Random Allocation; Rats; Rats, Inbred SHR; Telmisartan; Weight Gain | 2014 |
Angiotensin II AT1 receptor blockade by telmisartan reduces impairment of spatial maze performance induced by both acute and chronic stress.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Benzoates; Male; Maze Learning; Rats, Wistar; Receptor, Angiotensin, Type 1; Stress, Psychological; Telmisartan; Weight Gain | 2015 |
Lack of weight gain after angiotensin AT1 receptor blockade in diet-induced obesity is partly mediated by an angiotensin-(1-7)/Mas-dependent pathway.
Topics: Angiotensin I; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Animals, Genetically Modified; Benzimidazoles; Benzoates; Diet; Energy Intake; Energy Metabolism; Insulin Resistance; Leptin; Male; Obesity; Peptide Fragments; Proto-Oncogene Mas; Proto-Oncogene Proteins; Rats; Receptors, G-Protein-Coupled; Signal Transduction; Telmisartan; Weight Gain; Weight Loss | 2015 |
Neuroendocrine characterization and anorexigenic effects of telmisartan in diet- and glitazone-induced weight gain.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Anorexia; Benzimidazoles; Benzoates; Blood Glucose; Body Composition; Body Weight; Diet; Drinking Behavior; Feeding Behavior; Hypoglycemic Agents; Insulin; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Neurosecretory Systems; Pioglitazone; Receptor, Angiotensin, Type 1; Reverse Transcriptase Polymerase Chain Reaction; Telmisartan; Thiazolidinediones; Weight Gain | 2010 |
Telmisartan ameliorates hyperglycemia and metabolic profile in nonobese Cohen-Rosenthal diabetic hypertensive rats via peroxisome proliferator activator receptor-gamma activation.
Topics: Adiponectin; Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Benzoates; Blood Pressure; Humans; Hyperglycemia; Hypertension; Insulin; Insulin Resistance; Leptin; PPAR gamma; Rats; Rats, Inbred SHR; Rosiglitazone; Telmisartan; Thiazolidinediones; Tumor Necrosis Factor-alpha; Weight Gain | 2010 |
Telmisartan prevents weight gain and obesity through activation of peroxisome proliferator-activated receptor-delta-dependent pathways.
Topics: Adipocytes; Adipose Tissue; Analysis of Variance; Animals; Benzimidazoles; Benzoates; Blotting, Western; Cell Differentiation; Cells, Cultured; Dietary Fats; Dose-Response Relationship, Drug; Drug Administration Schedule; Eating; Fluorescent Antibody Technique; Mice; Mice, Knockout; Obesity; PPAR delta; Signal Transduction; Telmisartan; Uncoupling Agents; Weight Gain | 2010 |
Telmisartan improves nonalcoholic steatohepatitis in medaka (Oryzias latipes) by reducing macrophage infiltration and fat accumulation.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Antihypertensive Agents; Benzimidazoles; Benzoates; Carnitine O-Palmitoyltransferase; Cell Movement; Disease Models, Animal; Fats; Fatty Liver; Gene Expression; Humans; Macrophages; Non-alcoholic Fatty Liver Disease; Oryzias; Oxidative Stress; PPAR gamma; Telmisartan; Weight Gain | 2011 |
Double blockade of angiotensin II (AT(1) )-receptors and ACE does not improve weight gain and glucose homeostasis better than single-drug treatments in obese rats.
Topics: Adipose Tissue; Adrenocorticotropic Hormone; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Benzimidazoles; Benzoates; Blood Glucose; Blood Pressure; Corticosterone; Drug Therapy, Combination; Feeding Behavior; Heart Rate; Leptin; Male; Obesity; Ramipril; Rats; Rats, Inbred SHR; Telmisartan; Weight Gain | 2012 |
Identification of telmisartan as a unique angiotensin II receptor antagonist with selective PPARgamma-modulating activity.
Topics: Adipocytes; Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Benzoates; Biphenyl Compounds; Blood Glucose; Cell Differentiation; Cells, Cultured; Chlorocebus aethiops; Drug Evaluation, Preclinical; Gene Expression Regulation; Imidazoles; Insulin; Irbesartan; Losartan; Male; Mice; Models, Molecular; Myoblasts; Protein Conformation; Rats; Rats, Sprague-Dawley; Receptors, Cytoplasmic and Nuclear; Rosiglitazone; Structure-Activity Relationship; Telmisartan; Tetrazoles; Thiazoles; Thiazolidinediones; Thiazolidines; Transcription Factors; Triglycerides; Valine; Valsartan; Weight Gain | 2004 |
Telmisartan but not valsartan increases caloric expenditure and protects against weight gain and hepatic steatosis.
Topics: Adipocytes; Adipose Tissue; Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Benzoates; Cell Count; Cell Size; Energy Metabolism; Fatty Liver; Gene Expression; Male; Mitochondria; Rats; Rats, Sprague-Dawley; Telmisartan; Tetrazoles; Valine; Valsartan; Weight Gain | 2006 |
Telmisartan prevents the glitazone-induced weight gain without interfering with its insulin-sensitizing properties.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Benzimidazoles; Benzoates; Drug Evaluation, Preclinical; Drug Interactions; Insulin; Insulin Resistance; Male; Obesity; Rats; Rats, Sprague-Dawley; Rats, Zucker; Telmisartan; Thiazolidinediones; Weight Gain | 2007 |
Telmisartan increases fatty acid oxidation in skeletal muscle through a peroxisome proliferator-activated receptor-gamma dependent pathway.
Topics: Adiposity; Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Benzoates; Fatty Acids; Losartan; Male; Muscle, Skeletal; Oxidation-Reduction; PPAR gamma; Rats; Rats, Sprague-Dawley; Rats, Wistar; Telmisartan; Weight Gain | 2008 |